Steven Axon serves as Executive at Apellis Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Steven Axon has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 14, 2018 involved exercising options for 11,500 shares valued at $29.8K.
Steven Axon currently holds 50,110 shares of Apellis Pharmaceuticals, Inc. (APLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven Axon has been a net neutral trader of APLS stock. They have purchased $0 and sold $0 worth of shares.
Steven Axon's most recent insider trade was on Nov 14, 2018, when they sold 11,500 shares at $2.59 per share.
Get notified when new Form 4 filings are submitted
| 38,610 |
| $2.59 |
| Discretionary |